Literature DB >> 21491790

Merits of using color and shape differentiation to improve the speed and accuracy of drug strength identification on over-the-counter medicines by laypeople.

Elizabeth Hellier1, Mike Tucker, Natalie Kenny, Anna Rowntree, Judy Edworthy.   

Abstract

OBJECTIVE: This study aimed to examine the utility of using color and shape to differentiate drug strength information on over-the-counter medicine packages. Medication errors are an important threat to patient safety, and confusions between drug strengths are a significant source of medication error.
METHOD: A visual search paradigm required laypeople to search for medicine packages of a particular strength from among distracter packages of different strengths, and measures of reaction time and error were recorded.
RESULTS: Using color to differentiate drug strength information conferred an advantage on search times and accuracy. Shape differentiation did not improve search times and had only a weak effect on search accuracy.
CONCLUSIONS: Using color to differentiate drug strength information improves drug strength identification performance. Color differentiation of drug strength information may be a useful way of reducing medication errors and improving patient safety.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21491790     DOI: 10.1097/pts.0b013e3181eee157

Source DB:  PubMed          Journal:  J Patient Saf        ISSN: 1549-8417            Impact factor:   2.844


  5 in total

Review 1.  Design and comprehensibility of over-the-counter product labels and leaflets: a narrative review.

Authors:  Vivien Tong; David K Raynor; Parisa Aslani
Journal:  Int J Clin Pharm       Date:  2014-07-01

Review 2.  Defining Patient Centric Pharmaceutical Drug Product Design.

Authors:  Sven Stegemann; Robert L Ternik; Graziano Onder; Mansoor A Khan; Diana A van Riet-Nales
Journal:  AAPS J       Date:  2016-06-17       Impact factor: 4.009

3.  Users' preferences and perceptions of the comprehensibility and readability of medication labels.

Authors:  Emilia da Silva Pons; Cassia Garcia Moraes; Maicon Falavigna; Lisana Reginini Sirtori; Fernanda da Cruz; Guilherme Webster; Tatiane da Silva Dal Pizzol
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

4.  A drug by any other name: patients' ability to identify medication regimens and its association with adherence and health outcomes.

Authors:  Jennifer L Lenahan; Danielle M McCarthy; Terry C Davis; Laura M Curtis; Marina Serper; Michael S Wolf
Journal:  J Health Commun       Date:  2013

5.  Prescription stimulant brand name recognition among a national sample of 10- to 18-year-old youth.

Authors:  Linda B Cottler; Sonam O Lasopa; Catherine W Striley; Theodore J Cicero; Nicole D Fitzgerald; Arbi Ben Abdallah
Journal:  Int J Methods Psychiatr Res       Date:  2021-07-10       Impact factor: 4.035

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.